These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10494371)
1. [Blood and plasma product safety from the viewpoint of public health officials]. Willkommen H Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):497-500. PubMed ID: 10494371 [No Abstract] [Full Text] [Related]
2. [Blood and plasma product safety from viewpoint of the surgeon]. Kussmann J Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):495-7. PubMed ID: 10494370 [No Abstract] [Full Text] [Related]
3. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Turner ML; Ludlam CA Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452 [TBL] [Abstract][Full Text] [Related]
4. [Hemostasis and transfusion aspects of blood and plasma product safety]. Seyfert UT; Mörsdorf S; Mertzlufft F Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):488-92. PubMed ID: 10494368 [No Abstract] [Full Text] [Related]
6. [Physician liability and patient information related to blood and plasma product safety]. Bock RW Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):501-3. PubMed ID: 10494372 [No Abstract] [Full Text] [Related]
7. [Virologic aspects of blood and plasma product safety]. Gärtner BC; Mueller-Lantzsch N Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):486-8. PubMed ID: 10494367 [No Abstract] [Full Text] [Related]
8. Health outcomes research using large donor-recipient databases: a new frontier for assessing transfusion safety and contributing to public health. Busch M; Custer B Vox Sang; 2006 Nov; 91(4):282-4. PubMed ID: 17105602 [No Abstract] [Full Text] [Related]
9. [The clinical indications for and risks of fresh frozen plasma. A consensus conference. The Ministry of Health and Consumer Affairs]. Angiologia; 1993; 45(5):184-7. PubMed ID: 8285367 [No Abstract] [Full Text] [Related]
10. Infectious disease in the blood supply and the public health response. Evatt B Semin Hematol; 2006 Apr; 43(2 Suppl 3):S4-9. PubMed ID: 16631825 [TBL] [Abstract][Full Text] [Related]
11. Current estimates of transfusion safety worldwide. Dodd RY Dev Biol (Basel); 2005; 120():3-10. PubMed ID: 16050149 [TBL] [Abstract][Full Text] [Related]
12. [The safety of blood and plasma products]. Mertzlufft F; Wilhelm W Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):485-6. PubMed ID: 10494366 [No Abstract] [Full Text] [Related]
13. [Understanding the role of the European public institutions in blood transfusion]. Behr-Gross ME Transfus Clin Biol; 2009 May; 16(2):237-40. PubMed ID: 19443256 [TBL] [Abstract][Full Text] [Related]
14. Pathogen reduction technologies: what are the concerns? AuBuchon JP Vox Sang; 2004 Jul; 87 Suppl 2():84-9. PubMed ID: 15209887 [No Abstract] [Full Text] [Related]
17. Availability, safety and quality of blood for transfusion in the Americas. Cruz JR; Pérez-Rosales MD World Hosp Health Serv; 2005; 41(1):25, 27-31. PubMed ID: 15881823 [TBL] [Abstract][Full Text] [Related]
18. Risk assessment and cost-effectiveness/utility analysis. Busch M; Walderhaug M; Custer B; Allain JP; Reddy R; McDonough B Biologicals; 2009 Apr; 37(2):78-87. PubMed ID: 19243972 [TBL] [Abstract][Full Text] [Related]